Introduction
============

Upon contact with the host cells many pathogens use intercellular communication mechanisms for the regulation of virulence factors expression. One of the newest strategies for the prevention and treatment of bacterial infections is the inhibition of cell-to-cell signalling by inhibitors which do not interfere with the microbial growth \[[@b1-ijms-08-00583]\]. *Pseudomonas aeruginosa* is an increasingly prevalent opportunistic pathogen and is the most common Gram-negative bacterium found in nosocomial and life threatening infections of immunocompromised patients \[[@b2-ijms-08-00583]\]. *P. aeruginosa*, besides its natural resistance to a large number of antibiotics effective against other Gram-negative bacilli such as the A group penicillins, 1st-3rd generation cephalosporins, tetracyclins and trimetoprim, has developed acquired resistance to the so-called "antipseudomonals": carboxypenicillins (ticarcillin, carbenicillin, 25--30 % resistance), acyl-ureidopenicillins (cephtazidime, cephsulodin), carbapenems (imipenem, 20--25 %), gentamycin (47 %) and ciprofloxacin (35--40 %).

The intrinsic resistance of *Pseudomonas* cells towards antimicrobial agents is further increased when the bacteria is growing in biofilms. In fact, biofilms are known for their high resistance to antimicrobial agents, thus explaining their implication in the etiology of infectious diseases, with an incidence as high as 65 % \[[@b2-ijms-08-00583]\]. Human *P. aeruginosa* infections involving bacterial adherence and biofilm development on medical devices are very difficult to treat and eradicate, due to their increased resistance to the anti-infective host defense \[[@b3-ijms-08-00583]\]. The attempts made until present to attenuate bacterial pathogenesis due to *P. aeruginosa* by interfering with bacterial cell to cell communication, without interfering with growth have used natural antagonists produced by superior organisms (furanones) or chemically synthesized \[[@b6-ijms-08-00583]\].

The present study was aimed at attenuating the pathogenicity in *P. aeruginosa* by using subinhibitory concentrations of phenyl lactic acid (PLA). Our approach is based on the fact that this compound was found in the cell-free cultures of *Lactobacillus* probiotic strains and its antibacterial activity was already demonstrated for Gram-positive microorganisms \[[@b7-ijms-08-00583]\]. Our previous studies with cell-free probiotic cultures liquids have also demonstrated that the probiotic bacteria secrete soluble factors interfering with the pathogenic bacteria and host cell signaling mechanisms, in the first case by inducing changes in the expression of surface molecules and consequently, the shift of the adherence pattern from aggregative to the diffuse one, and the stimulation of endocytic processes of cultured cells, respectively \[[@b8-ijms-08-00583]\].

Results and Discussion
======================

The ability of pathogenic bacteria to survive in different environments illustrates the importance of understanding the regulation of bacterial virulence genes and those implicated in the detection of the environmental signals for the elaboration of adequate anti-infective strategies \[[@b9-ijms-08-00583]\]. The success of any pathogen in the colonization of a sensitive host and the development of an infectious process is dependent on its ability to sense its environment and to modulate the expression of the gene encoding factors required for the establishment and adaptation to the new habitat \[[@b10-ijms-08-00583]\].

For opportunistic bacteria, such as *Pseudomonas aeruginosa*, the outcome of the complex bacterial cell-host interactions depend on cellular density \[[@b3-ijms-08-00583]\]. Our *in vivo* experimental study using a holoxenic mice infection model showed that subinhibitory concentrations of PLA could act as a potent inhibitor of *P. aeruginosa* pathogenicity, without affecting the bacterial cells viability, this antagonistic effect depending on the infection route and the microbial tested strain.

Conclusions
===========

The present study has proved the role of subinhibitory concentrations of PLA in the attenuation of *P. aeruginosa* virulence and pathogenicity, using an *in vivo* holoxenic mouse infection experimental model. Our results are accounting for the hypothesis that subinhibitory concentrations of PLA, which are not acting by affecting the bacterial cell viability, are probably interferring with the intracellular communication and the sequential and coordinated expression of different virulence factors, altering the success of this pathogen in the colonization of a sensitive host and the development of an infectious process.

Experimental
============

General
-------

The pathogenic *Ps. aeruginosa* strains used in our study were isolated in 2006 from invasive infections and identified comparatively by classical biochemical reactions and API 20NE microtests (BioMérieux). *D*-3-phenyl lactic acid, purity ≥97.0 % (PLA, [Figure 1](#f1-ijms-08-00583){ref-type="fig"}) supplied by Sigma-Aldrich Division (Milan, Italy) was used in the study.

Conventional (holoxenic) mice, purchased from Darvari Farm (Bucharest), were used in these experiments. In order to obtain comparative results the animals were grouped in different batches of five animals each as follows: one negative control (batch 1) and six infection batches and six batches for investigation of the influence of PLA on bacterial pathogenicity. Each batch contained 5 animals.

Study design
------------

The bacterial strains were seeded on agar medium and incubated for 24 hours at 37 °C. Starting from isolated colonies developed on the agar medium, microbial suspensions of 0.5. MacFarland density (1--3×10^8^ CFU/ml) were prepared in sterile saline. 100 μl of this inoculum were distributed in two culture tubes for each strain, one containing 10 ml nutrient broth and the other one 10 ml nutrient broth with *D*-3-phenyl lactic acid at a final concentration of 1 mg/ml. The concentration of PLA used in this study (1 mg/ml) proved to be subinhibitory for all tested strains, meaning that it did not affect the cultures viability, as demonstrated by the viable cell counts (CFU/ml) performed on the inoculum giving similar values in the presence as well as in the absence of *D*-3-phenyllactic acid. The initial solution of 100 mg/ml was prepared in vol:vol methanol:water solution. The solution was sterilised by 22 μm filter mambrane. After adding the *D*-3-phenyllactic acid in the nutrient broth, the pH medium was controlled (in order to exclude the medium acidification due to the addition of the PLA). The two tubes were incubated for 24 hours at 37 °C. The obtained overnight cultures of *P. aeruginosa* grown with and without addition of subinhibitory concentrations of PLA (1 mg/ml) were centrifuged and the sediment was washed three times in PBS (phosphate buffered saline). Starting from the cell sediment, bacterial suspensions of \~10^7^ CFU/ml were prepared in PBS and used for mice inoculation in one single dose given by oral (p.o.), intranasal (i.n.), intravenous (i.v.), and intraperitoneal (i.p.) routes. The mice were followed up to 16 days after infection and the body weight, mortality and morbidity rate were measured at different time intervals. The course of infection was determined by daily examination of the animals in each batch, as well as by final viable cell count (Colony Forming Units, CFU number) performed on different organs and tissues, in order to appreciate the pathogen invasion (lungs, spleen, intestinal mucosa and blood). The tissue specimens (collected after the animals died from infection or were euthanized) were weighted and homogenised in sterile PBS. Serial ten-fold dilutions from homogenate were plated (0.1. ml/plate) onto King A medium specific for the isolation and counting of *P. aeruginosa.* The seeded media were incubated at 37 °C for 24 hours and the specific *P. aeruginosa* colonies were counted and the results were expressed in CFU/ml.
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###### 

Mortality and body weight dynamics in animals infected with *P. aeruginosa* wild cultures.

  No.    Bacterial strain/Inoculation mode   Day 0   Day 1   Day 2                                
  ------ ----------------------------------- ------- ------- ------- ---- ---- ------- ---- ----- -------
  1\.    *P. aeruginosa* 247/1464 i.p.       5       107     26.75   2    20   10      1    23    23
  2\.    *P. aeruginosa* 247/1464 i.v.       5       102     25.5    --   --   --      --   --    --
  3\.    *P. aeruginosa* 247/1464 i.n.       5       92      23      4    90   22.5    4    90    22.5
  4\.    *P. aeruginosa* 492 i.p.            5       110     27.5    --   --   --      --   --    --
  5\.    *P. aeruginosa* 492 i.v.            5       99      24.75   3    55   18.53   --   --    --
  6\.    *P. aeruginosa* 492 i.n.            5       92      23      4    90   22.5    4    96    24
  7\.    *P. aeruginosa* 492 p.o.            5       94      23.5    4    90   22.5    4    94    23.5
  8\.    *P. aeruginosa* 37 i.p.             5       95      23.75   --   --   --      --   --    ----
  9\.    *P. aeruginosa* 37 i.v.             5       92      23      --   --   --      --   --    --
  10\.   *P. aeruginosa* 37 i.n.             5       92      23      4    89   22.25   4    96    24
  11\.   *P. aeruginosa* 37 p.o.             5       97      24.25   4    95   23.75   4    106   26.5
  12\.   *Ps. aeruginosa* 1489 i.p.          5       88      22      --   --   --      --   --    --
  13\.   *P. aeruginosa* 1489 i.v.           5       77      19.25   --   --   --      --   --    --
  14\.   *P. aeruginosa* 1489 i.n.           5       107     26.75   4    78   19.5    4    86    21.5
  15\.   *P. aeruginosa* 1489 p.o.           5       82      20.5    4    87   21.75   4    95    23.75
  16\.   Control                             5       74      18.5    4    76   19      4    76    19

  No.    Bacterial strain/Inoculation mode   Day 7   Day 9   Day 16                                 
  ------ ----------------------------------- ------- ------- -------- ---- ----- ------- ---- ----- -------
  1\.    *P. aeruginosa* 247/1464 i.p.       1       24      24       1    21    21      1    28    28
  2\.    *P. aeruginosa* 247/1464 i.v.       \-      \-      \-       \-   \-    \-      \-   \-    \-
  3\.    *P. aeruginosa* 247/1464 i.n.       4       95      23.75    4    95    23.75   4    107   26.75
  4\.    *P. aeruginosa* 247/1464 p.o.       4       93      23.25    4    100   25      4    112   28
  5\.    *P. aeruginosa* 492 i.p.            \-      \-      \-       \-   \-    \-      \-   \-    \-
  6\.    *P. aeruginosa* 492 i.v.            \-      \-      \-       \-   \-    \-      \-   \-    \-
  7\.    *P. aeruginosa* 492 i.n.            4       117     29.25    4    119   29.75   4    135   33.75
  8\.    *P. aeruginosa* 492 p.o.            4       105     26.25    4    105   26.25   4    117   29.25
  9\.    *P. aeruginosa* 37 i.p.             \-      \-      \-       \-   \-    \-      \-   \-    \-
  10\.   *P. aeruginosa* 37 i.v.             \-      \-      \-       \-   \-    \-      \-   \-    \-
  11\.   *Ps. aeruginosa* 37 i.n.            4       116     29       4    119   29.75   4    121   30.25
  12\.   *P. aeruginosa* 37 p.o.             4       118     29.5     4    123   30.75   4    122   30.5
  13\.   *P. aeruginosa* 1489 i.p.           \-      \-      \-       \-   \-    \-      \-   \-    \-
  14\.   *P. aeruginosa* 1489 i.v.           \-      \-      \-       \-   \-    \-      \-   \-    \-
  15\.   *P. aeruginosa* 1489 i.n.           4       118     27       4    112   28      4    130   32.5
  16\.   *P. aeruginosa* 1489 p.o.           4       100     25       4    120   30      4    138   34.5
  17\.   Control                             4       77      19.25    4    79    19.75   4    100   25

no. = number of mice/batch; g/b = gram/batch; g/m= gram/mouse; -- = animals died during the experiment

###### 

Mortality and body weight dynamics in animals infected with PLA treated *P. aeruginosa* cultures.

  No.    Bacterial strain/Inoculation mode   Day 0   Day 1   Day 2   Day 7   Day 9   Day 16                                                                   
  ------ ----------------------------------- ------- ------- ------- ------- ------- -------- --- ----- ------- --- ----- ------- --- ----- ------- --- ----- -------
  1\.    *P. aeruginosa* 247/1464 i.p.       5       122     30.5    4       118     29.5     4   120   30      4   130   32.5    4   140   35      4   149   37.25
  2\.    *P. aeruginosa* 247/1464 i.v.       5       120     30      4       127     31.75    4   132   33      4   135   33.75   4   143   35.75   4   148   37
  3\.    *P. aeruginosa* 247/1464 i.n.       5       130     32.5    4       135     33.75    4   122   30.5    4   141   35.25   4   146   36.5    4   150   37.5
  4\.    *P. aeruginosa* 247/1464 p.o.       5       130     32.5    4       119     29.75    4   140   35      4   143   35.75   4   155   38.75   4   158   39.5
  5\.    *P. aeruginosa* 492 i.p.            5       120     30      4       117     29.25    4   120   30      4   131   32.75   4   145   36.25   4   147   36.75
  6\.    *P. aeruginosa* 492 i.v.            5       115     28.75   4       119     29.75    4   120   30      4   129   32.25   4   138   34.5    4   144   36
  7\.    *P. aeruginosa* 492 i.n.            5       115     28.75   4       128     32       4   133   33,25   4   136   34      4   142   35,5    4   147   36.75
  8\.    *P. aeruginosa* 492 p.o.            5       120     30      4       123     30.75    4   124   31      4   139   34.75   4   147   36.75   4   152   38
  9\.    *P. aeruginosa* 37 i.p.             5       120     30      4       116     29       4   118   29.5    4   120   30      4   124   31      4   146   36.5
  10\.   *P. aeruginosa* 37 i.v.             5       120     30      4       124     31       4   122   30.5    4   122   30.5    4   145   36.25   4   152   38
  11\.   *Ps. aeruginosa* 37 i.n.            5       115     28.75   4       120     30       4   121   30.25   4   122   30.5    4   137   34.25   4   142   35.5
  12\.   *P. aeruginosa* 37 p.o.             5       120     30      4       122     30.5     4   122   30.5    4   135   33.75   4   144   36      4   148   37
  13\.   *P. aeruginosa* 1489 i.p.           5       110     27.5    4       106     26.5     3   70    23.33   3   72    24      2   58    29      2   62    31
  14\.   *P. aeruginosa* 1489 i.v.           5       130     32.5    4       120     30       4   130   32.5    4   120   30      4   148   37      4   150   37.5
  15\.   *P. aeruginosa* 1489 i.n.           5       120     30      4       117     29.25    4   119   29.75   4   119   29.75   3   92    30.6    3   105   35
  16\.   *P. aeruginosa* 1489 p.o.           5       120     30      4       110     27.25    4   120   30      4   125   31.25   4   122   30.5    4   137   34.25
  17\.   Control                             5       130     26      5       132     26.4     5   122   30.5    5   124   24.8    5   143   28.6    5   148   29.6

no. = number of mice/batch; g/b = gram/batch; g/m = gram/mouse; -- = animals died during the experiment

###### 

Viable cell counts (CFU/ml) in internal organ tissues of animal batches infected with untreated (PLA-) and PLA treated (PLA+) *P. aeruginosa* cultures.

  No.            Bacterial strain/Inoculation route   CFU/ml dil. 10^−6^   CFU/ml dil. 10^−7^   CFU/ml dil. 10^−8^   CFU/ml dil. 10^−9^                  
  -------------- ------------------------------------ -------------------- -------------------- -------------------- -------------------- ---- ---- ---- --
  1              *P. aeruginosa* 1489 **i.p.**                                                                                                           
  Gall bladder   NC                                   \-                   300                  --                   91                   --   5    --   
  Lung           NC                                   61                   460                  17                   80                   9    30   --   
  Intestine      100                                  20                   31                   --                   \-                   --   \-   --   
  Blood          NC                                   --                   NC                   --                   NC                   --   NC   --   
  2              *P. aeruginosa* 247/1464 **i.p.**                                                                                                       
  Gall bladder   NC                                   --                   173                  --                   95                   --   10   --   
  Lung           NC                                   --                   NC                   --                   121                  --   28   --   
  Intestine      NC                                   --                   NC                   --                   150                  --   60   --   
  Blood          NC                                   --                   NC                   --                   NC                   --   NC   --   
  3              *P. aeruginosa* 247/1464 **i.v.**                                                                                                       
  Gall bladder   107                                  --                   20                   --                   --                   --   --   --   
  Lung           241                                  --                   64                   --                   10                   --   \-   --   
  Intestine      26                                   --                   \-                   --                   --                   --   --   --   
  Blood          NC                                   --                   NC                   --                   NC                   --   NC   --   
  4              *P. aeruginosa* 492 **i.v.**                                                                                                            
  Gall bladder   NC                                   --                   NC                   --                   130                  --   80   --   
  Lung           300                                  --                   96                   --                   42                   --   4    --   
  Intestine      NC                                   --                   NC                   --                   50                   --   30   --   
  Blood          NC                                   --                   234                  --                   67                   --   7    --   
  5              *P. aeruginosa* 492 **i.v.**                                                                                                            
  Gall bladder   NC                                   --                   NC                   --                   NC                   --   NC   --   
  Lung           NC                                   --                   NC                   --                   27                   --   2    --   
  Intestine      NC                                   --                   NC                   --                   NC                   --   NC   --   
  Blood          --                                   --                   --                   --                   --                   --   --   --   
  6              *P. aeruginosa* 37 **i.p.**                                                                                                             
  Gall bladder   --                                   --                   --                   --                   --                   --   --   --   
  Lung           --                                   --                   --                   --                   --                   --   --   --   
  Intestine      --                                   --                   --                   --                   --                   --   --   --   
  Blood          --                                   --                   --                   --                   --                   --   --   --   
  7              *P. aeruginosa* 37 **i.v.**                                                                                                             
  Gall bladder   NC                                   --                   NC                   --                   NC                   --   NC   --   
  Lung           NC                                   --                   NC                   --                   NC                   --   NC   --   
  Intestine      10                                   --                   \-                   --                   --                   --   --   --   
  Blood          --                                   --                   --                   --                   --                   --   --   --   
  8              *P. aeruginosa* 1489 **i.p.**                                                                                                           
  Gall bladder   127                                  --                   21                   --                   --                   --   --   --   
  Lung           NC                                   --                   NC                   --                   260                  --   96   --   
  Intestine      NC                                   --                   NC                   --                   --                   --   --   --   
  Blood          NC                                   --                   NC                   --                   NN                   --   NC   --   
  9              *P. aeruginosa* 1489 **i.v.**                                                                                                           
  Gall bladder   NC                                   356                  186                  110                  62                   23   6    \-   
  Lung           NC                                   --                   NC                   --                   NC                   --   NC   --   
  Intestine      108                                  --                   36                   --                   --                   --   --   --   
  Blood          --                                   --                   --                   --                   --                   --   --   --   

NC- not countable at the chosen dilution
